ORION PHARMA A/S: Financial statements 2021
CVR: 20601116
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 212,530,416 and a net result of DKK 4,513,431 compared with DKK 6,315,388 the year before. That is a decrease of 24.9% compared with the year before. The profit margin was 2.1%. Equity in the 2021 report amounted to DKK 47,923,697. The solvency ratio was 55.3%. The company had 17 employees in the financial year.
- Revenue
- DKK 212,530,416
- Gross Profit
- DKK 20,686,857
- Profit/Loss
- DKK 4,513,431
- Equity
- DKK 47,923,697
- Total Assets
- DKK 86,680,195
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 212.5M | 20.7M | 4.5M | 47.9M | 17 |
| 2020 | 282.9M | 25.5M | 6.3M | 51.4M | 20 |
| 2019 | 280.9M | 43M | 16.9M | 57.6M | 24 |
| 2018 | 247.1M | 51M | 20.5M | 50.7M | 28 |
| 2017 | 327.7M | 73M | 37.8M | 95.2M | 29 |
Official annual report
Find more companies like ORION PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
ORION PHARMA A/S has published its annual report for 2020. Revenue came to DKK 282,867,433, and the net result was DKK 6,315,388.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.